Antimetastatic activity of a novel mechanism-based gelatinase inhibitor.
about
Novel therapeutic targets for pancreatic cancerInfluence of Immune Myeloid Cells on the Extracellular Matrix During Cancer MetastasisFull-length L1CAM and not its Δ2Δ27 splice variant promotes metastasis through induction of gelatinase expressionActive site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases.Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.Matrix metalloproteinase-2 promoter genotype as a marker of cutaneous T-cell lymphoma early stageSynthesis, kinetic characterization and metabolism of diastereomeric 2-(1-(4-phenoxyphenylsulfonyl)ethyl)thiiranes as potent gelatinase and MT1-MMP inhibitors.Drug-target residence time: critical information for lead optimization.Identification of a survival-independent metastasis-enhancing role of hypoxia-inducible factor-1alpha with a hypoxia-tolerant tumor cell lineMatrix metalloproteinases in tumorigenesis: an evolving paradigm.Exploration of mild copper-mediated coupling of organotrifluoroborates in the synthesis of thiirane-based inhibitors of matrix metalloproteinasesHalofuginone suppresses the lung metastasis of chemically induced hepatocellular carcinoma in rats through MMP inhibition.Selective water-soluble gelatinase inhibitor prodrugs.Conformational analyses of thiirane-based gelatinase inhibitorsSynthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitorsMatrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.Structure-Activity Relationship for Thiirane-Based Gelatinase InhibitorsMatrix Metalloproteinases and Bladder Cancer: What is New?Towards third generation matrix metalloproteinase inhibitors for cancer therapyThe initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.Epidermal growth factor-like repeats of thrombospondins activate phospholipase Cgamma and increase epithelial cell migration through indirect epidermal growth factor receptor activationA potent gelatinase inhibitor with anti-tumor-invasive activity and its metabolic dispositionMatrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background.Therapeutic modulation of prostate cancer metastasis.Metastasis review: from bench to bedside.Blockade of MMP-2 and MMP-9 inhibits corneal lymphangiogenesis.Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation.Triggering of T-cell leukemia and dissemination of T-cell lymphoma in MMP-9-deficient mice.Allyl isothiocyanate and its N-acetylcysteine conjugate suppress metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in SK-Hep 1 human hepatoma cells.Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment.Porphyromonas gingivalis initiates a mesenchymal-like transition through ZEB1 in gingival epithelial cells.CD44 regulates prostate cancer proliferation, invasion and migration via PDK1 and PFKFB4.Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition.Inhibition of MMP-9 activity following hypoxic ischemia in the developing brain using a highly specific inhibitor.Matrix metalloproteinase-9 potentiates early brain injury after subarachnoid hemorrhage.Discovery of Mechanism-Based Inactivators for Human Pancreatic Carboxypeptidase A from a Focused Synthetic Library.Protease nexin-1 prevents growth of human B cell lymphoma via inhibition of sonic hedgehog signaling.Primitive macrophages control HSPC mobilization and definitive haematopoiesis.
P2860
Q24564267-559C20F1-1963-422E-B950-F1B5093E7895Q26767150-BD545C88-CCA7-4D1F-B6B4-3562362DD1DDQ28740779-FEE2CEB7-7362-408E-80E6-0A4E54E197C7Q33723218-3B4FCA31-38C2-4580-8FD4-3B7CB11D5E38Q33757096-71F87B6C-6B6B-428F-A1BA-533AC76A8797Q33961025-A8E16EBD-16C6-4BB5-A8CF-89A7202BFF0CQ33983963-36B7EC75-82CE-4E04-8793-65182C615281Q34054343-0DF42CBF-5E65-4AD3-BB45-A8E81BA3D663Q34074343-1EEE617E-FEF1-4B6C-A74A-7AC9EBEE7679Q34199345-129C6F3B-C01A-4EBA-999E-4B0EF2F7F6F1Q34851893-9A9B25BF-E06B-42DA-BAFC-3636A612BC92Q35081499-0FD40D3A-6697-4777-9C86-D71FD6F79556Q35308826-F724C4C3-4B5B-41F6-A533-AD4EAB18FEF2Q35777953-8BB7432E-6E9C-461B-8B17-36B2E14A6510Q35871254-AEF64815-85B7-4833-B7D8-E107A53F704CQ36009930-0B6AADE7-30EC-40C1-93C4-0866CDFC7D53Q36048569-5FE340DA-020B-4CEA-9550-D21AD73DDF79Q36125093-0ED6FFB2-AC54-4CA4-8AF4-6C3798534706Q36421691-122CC1B1-BF92-4D71-877F-E3043284F7CAQ36494563-6069F1E1-DC02-4D10-9F38-23C3347F64A6Q36644577-D5F5D13A-9AE5-4227-AF5B-D8A4C77B677FQ37112224-16738230-895F-45FA-B817-DA02FEA09BCDQ37355131-18AD5871-A691-417C-ABB5-8245E63EB87FQ37412311-B1F942E9-4E44-467A-B0D8-15A90F5C62C4Q37461337-97D14088-1B01-439F-BA31-B63A880F405CQ38182140-76E998E6-B885-4E22-BA6E-818F2CB07AEDQ38237985-BC615F20-043F-46BB-AE47-804F81CDD01FQ38698186-DD6D6417-CD21-4ED1-9B0E-361BB37961E2Q39102655-7664C0FC-874B-4517-8D49-79F90CF3E13CQ40084237-2A8478CE-0D7B-4D61-AAEC-D1131BEFA6EEQ40299760-FBCEBB65-59A1-4FD8-8976-37EE99DD26CCQ40333118-47B2E0C8-1B49-4698-8ADE-F60E87F70F9AQ40881730-3FDEEC34-3326-4449-AA3B-C4536DA19C85Q42371512-79D50556-9469-4202-ACD4-9BCDC6980628Q47374773-4AEB65C1-B594-43E9-BB16-C6D0AC5B0820Q48284943-1850B1BE-F6B4-497B-B3A3-586A770D7CE4Q48477294-BCD3953A-482B-402B-B6FC-13C9DDEFF7E5Q50066125-C6B91278-C63F-40D5-93AE-9CEA82CF437BQ50317219-A2A269D7-A768-4F55-A623-CB39A58751D3Q50600768-2C63650E-CD34-48EA-B4F9-2A0074CBCAB3
P2860
Antimetastatic activity of a novel mechanism-based gelatinase inhibitor.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Antimetastatic activity of a novel mechanism-based gelatinase inhibitor.
@en
type
label
Antimetastatic activity of a novel mechanism-based gelatinase inhibitor.
@en
prefLabel
Antimetastatic activity of a novel mechanism-based gelatinase inhibitor.
@en
P2093
P1433
P1476
Antimetastatic activity of a novel mechanism-based gelatinase inhibitor.
@en
P2093
Achim Krüger
Charlotte Kopitz
M Margarida Bernardo
Matthias J E Arlt
Mayland Chang
Michael Gerg
Rafael Fridman
Shahriar Mobashery
P304
P356
10.1158/0008-5472.CAN-04-3570
P407
P577
2005-05-01T00:00:00Z